Evidence Library
Filter by drug, type, year, and open access.
Showing 1–4 of 4 results
- GLP-1 receptor agonists for atypical antipsychotic-related metabolic dysfunctions (systematic review) — Experimental and Therapeutic Medicine (2023)• Drug: tirzepatide-zepboundOpen accessPMIDPMCID
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) — New England Journal of Medicine (2022)• Drug: tirzepatide-zepboundDOI
- Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2) — New England Journal of Medicine (2021)• Drug: tirzepatide-zepboundDOI
- Liraglutide for Prediabetes/Obesity in Clozapine- or Olanzapine-Treated Schizophrenia Spectrum Disorder (RCT) — JAMA Psychiatry (2017)• Drug: tirzepatide-zepboundOpen accessPMIDPMCID